Translate Bio, Inc. (TBIO): Price and Financial Metrics
TBIO Price/Volume Stats
| Current price | $0.05 | 52-week high | $6.17 |
| Prev. close | $0.25 | 52-week low | $0.01 |
| Day low | $0.05 | Volume | 100 |
| Day high | $0.05 | Avg. volume | 6,906 |
| 50-day MA | $0.45 | Dividend yield | N/A |
| 200-day MA | $1.62 | Market Cap | 90.10K |
TBIO Stock Price Chart Interactive Chart >
Translate Bio, Inc. (TBIO) Company Bio
Translate Bio, Inc., a messenger RNA therapeutics company, engages in developing medicines to treat diseases caused by protein or gene dysfunction. It is developing MRT5005 that is in Phase I/II clinical trial for the treatment of cystic fibrosis; and MRT5201 for the treatment of ornithine transcarbamylase deficiency. It has strategic alliances with Sanofi Pasteur. The company was formerly known as RaNA Therapeutics, Inc. and changed its name to Translate Bio, Inc. in June 2017. Translate Bio, Inc. was founded in 2011 and is based in Lexington, Massachusetts.
TBIO Latest News Stream
| Event/Time | News Detail | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
TBIO Price Returns
| 1-mo | 334.78% |
| 3-mo | N/A |
| 6-mo | -90.99% |
| 1-year | -98.68% |
| 3-year | -99.92% |
| 5-year | N/A |
| YTD | -87.50% |
| 2024 | -94.43% |
| 2023 | -66.75% |
| 2022 | -88.89% |
| 2021 | N/A |
| 2020 | N/A |